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Summary
Presence of scar as depicted by LGE on CMR is a strong
predictor of death and hard clinical endpoints. LGE on
CMR may hence be considered a significant variable in
the risk prediction equation for patients with HCM.
Background
Patients with hypertrophic cardiomyopathy (HCM)
represent a heterogeneous group at risk of death and
other cardiac events, necessitating further effective risk
stratification. Late gadolinium enhancement (LGE) on
cardiac MR (CMR) represents fibrosis and has emerged
as a possible risk predictor of hard events in several
small studies. We sought to evaluate the prognostic uti-
lity of LGE in patients with HCM by performing a meta
analysis of available studies.
Methods
PubMed, Cochrane Register of Controlled Trials, confer-
ence proceedings, and internet-based resources of clini-
cal trials. Studies evaluating the prognostic utility of
LGE on CMR with outcomes of interest including
death, aborted sudden cardiac death (SCD) were
included. We used the risk ratio (RR) with 95% confi-
dence intervals (CIs) as the metric of choice for out-
comes. Categorical variables were reported as
percentages and continuous variables are presented as
means +/- standard deviation. Weighted means were
used for the pooled estimates of continuous variables.
The pooled RR was calculated with the DerSimonian-
Laird method for random effects. To assess heterogene-
ity across trials, we used the Cochran Q via a 2 test
based on the pooled RR by Mantel-Haenszel, as well as
the I2 statistic.
Results
Four studies comprising of 1063 patients without history
of septal ablation or myectomy with mean (weighted)
age of 51+14 with 68% male subjects formed the study
population. There were 634 (59%) patients in LGE+
group and 429 (41%) patients in LGE- group. Mean
duration of follow up was 34.5 + 9 months (range 22-43
months). Presence of LGE+ was associated with
increased risk of all cause mortality and surrogates of
SCD At follow up, hard events occurred in 71 patients
(12%) in the +LGE group and 10 events (2.3%) in the
LGE- group translating into a relative risk of 3.61 (1.29,
10.05); p=0.01. There was little heterogeneity with
regards to the end point (I2=41%)
Conclusions
Presence of scar as depicted by LGE on CMR is a strong
predictor of death and hard clinical endpoints. LGE on
CMR may hence be considered a significant variable in
the risk prediction equation for patients with HCM.
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